目的探讨高浓度地塞米松对骨髓间充质干细胞(BMSCs)小分子非编码RNA(sncRNA)表达的调控机制。方法体外分离并培养小鼠BMSCs,阴性对照组(NC组)与地塞米松组(DEX组)分别使用含0.1 μmol/L、10 μmol/L地塞米松的诱导液进行诱导。通过茜素红染色分析BMSCs的成骨分化情况。运用Illumina Hiseq 2500平台进行高通量small RNA测序,筛选NC组与DEX组差异表达的sncRNAs,并进行生物信息学分析。结果茜素红染色结果显示,与NC组相比,DEX组茜素红染色变浅,半定量检测结果显示DEX组钙结节含量显著降低。DEX组与NC组的差异基因中,|log2Fold Change|≥1的微小RNA(miRNA)有25个,其中DEX组的6个miRNAs表达上调,19个miRNAs表达下调(均P<0.05)。基因本体论(GO)分析结果显示,上调的差异miRNAs的靶基因主要参与蛋白质磷酸化、肌肉和器官发育、细胞黏附等生物过程,下调的差异miRNAs的靶基因主要参与蛋白质自磷酸化、蛋白质泛素化、细胞内雌激素受体信号通路、细胞增殖等生物过程。京都基因与基因组百科全书(KEGG)分析显示,上调的差异miRNAs主要富集在脂肪合成相关信号通路、Ras信号通路、钙信号通路等,下调的差异miRNAs主要富集在Wnt信号通路、Hippo信号通路等。DEX组与NC组的差异基因中,|log2Fold Change|≥1的PIWI相互作用RNA(piRNA)有3个,其中DEX组的1个piRNA表达上调,2个piRNAs表达下调;|log2Fold Change|≥1的重复相关小于扰RNA(rasiRNA)有2个,两者在DEX组中的表达均上调;|log2Fold Change|≥1的核仁小(snoRNA)有8个,其中DEX组有6个snoRNAs表达上调,2个snoRNAs表达下调;|log2Fold Change|≥1的核小RNA(snRNA)仅有1个,该基因在DEX组中表达下调(均P<0.05)。结论高通量small RNA测序技术能够有效检测到经高浓度地塞米松处理后小鼠BMSCs中差异表达的sncRNAs,且信号通路分析提示差异表达的miRNAs可能参与脂肪代谢和成骨代谢等多个生物学过程。
ObjectiveTo explore the regulation mechanism of high-concentration dexamethasone on small non-coding RNA (sncRNA) expressions of bone marrow mesenchymal stem cells (BMSCs). MethodsBMSCs of mice were isolated and cultured in vitro; meanwhile, the negative control group (NC group) and the dexamethasone group (DEX group) were induced by the solutions including 0.1 μmol/L or 10 μmol/L dexamethasone, respectively. The states of BMSCs osteogenic differentiations were analyzed via alizarin red staining. The high throughput small RNA sequencing was conducted, the differential expressions of sncRNAs in both NC and DEX groups were screened, and the bio-informatics was analyzed by employing the Illumina Hiseq 2500 platform. ResultsTo compared with the NC group, the DEX group had a lighter alizarin red staining based on results of alizarin red staining, and yielded significantly lower content of calcium nodule via results of the semi-quantitative detection. There were 25 micro RNAs (miRNAs) with |log2Fold Change| ≥1 of the differential genes in both DEX and NC groups, among which in the DEX group, 6 miRNAs expressed in up-regulation, whereas 19 miRNAs in down-regulated expressions (all P<0.05). The Gene Ontology (GO) results interpreted that the target genes of up-regulated differential miRNAs were mainly involved in biological processes of protein phosphorylation, muscle and organs developments, and cell adhesion etc., and the target genes of down-regulated differential miRNAs were mainly involved in the biological processes of protein auto-phosphorylation, protein ubiquitination, intracellular estrogen receptor signaling pathway, and cell proliferation etc.. The Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that up-regulated differential miRNAs were mainly enriched in fat synthesis related signaling pathway, Ras or calcium signaling pathway etc., whereas down-regulated differential miRNAs were mainly enriched in Wnt or Hippo signaling pathway etc.. Among those differential genes in both DEX and NC groups, there were 3 PIWI-interacting RNAs (piRNAs) with |log2Fold Change| ≥1, thereinto the DEX group had 1 piRNA in up-regulated expression, whereas 2 piRNAs in down-regulated expressions; furthermore, there were 2 repeat associated small interfering RNAs (rasiRNAs) with |log2Fold Change| ≥1, all expressed in up-regulation in the DEX group; moreover, 8 small nucleolar RNAs (snoRNAs) interpreted in |log2Fold Change| ≥1, of which the DEX group had 6 in up-regulated expressions, whereas 2 in down-regulation; in addition, only one small nuclear RNA (snRNA) expressed in |log2Fold Change| ≥1, which was down-regulated expression in the DEX group (all P<0.05). ConclusionThe sequencing technology of high throughput small RNA can effectively detect the differential expressions of sncRNAs in BMSCs of mice treated with high-concentration dexamethasone, and the analysis of signaling pathways presented that differential expressed miRNAs may involve in multiple biological processes of fat and osteogenesis metabolism etc..